Oliver Lagore Vanvalin Investment Group Fortress Biotech, Inc. Transaction History
Oliver Lagore Vanvalin Investment Group
- $334 Million
- Q1 2024
Shares
1 transactions
Others Institutions Holding FBIO
# of Institutions
6Shares Held
1.01MCall Options Held
0Put Options Held
0-
Cpwm, LLC Seattle, WA762KShares$1.37 Million0.06% of portfolio
-
National Asset Management, Inc. Boca Raton, FL145KShares$260,4600.01% of portfolio
-
Telemetry Investments, L.L.C. New York, NY72KShares$129,6000.07% of portfolio
-
Dowling & Yahnke LLC San Diego, CA20KShares$36,0000.01% of portfolio
-
Urban Wealth Management, LLC7.64KShares$13,7430.02% of portfolio
About Fortress Biotech, Inc.
- Ticker FBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,735,000
- Market Cap $194M
- Description
- Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch sympt...